Recalcitrant Atopic Dermatitis Treated with Omalizumab

Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease. Various categories of therapeutic medications are used for treating AD. Omalizumab is a monoclonal anti-IgE antibody that binds to IgE molecules at the high-affinity receptor (FcεRI) binding site. Therefore, omalizumab can be used a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Park, Se-Young, Choi, Mi-Ra, Na, Jung-Im, Youn, Sang-Woong, Park, Kyoung-Chan, Huh, Chang-Hun
Formato: Artigo
Idioma:Inglês
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2010
Assuntos:
Case Report
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917695/
https://ncbi.nlm.nih.gov/pubmed/20711278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2010.22.3.349
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares